Response rate according to baseline patient features (n = 31)
| . | No. of patients (%) . | |||||
|---|---|---|---|---|---|---|
| OR . | CR . | CRu . | PR . | NC . | PD . | |
| Total group (n = 31) | 27 (87%) | 7 (23%) | 3 (10%) | 17 (55%) | 1 (3%) | 3 (9%) |
| First-line patient (n = 20) | 17 (85%) | 4 (20%) | 1 (5%) | 12 (60%) | — | 3 (15%) |
| Pretreated patient (n = 11) | 10 (90%) | 3 (27%) | 2 (18%) | 5 (45%) | 1 (9%) | — |
| Binet B (n = 21) | 20 (95%) | 6 (29%) | 3 (14%) | 11 (52%) | — | 1 (5%) |
| Binet C (n = 10) | 7 (70%) | 1 (10%) | — | 6 (60%) | 1 (10%) | 2 (20%) |
| No B-symptoms (n = 15) | 12 (80%) | 1 (7%) | 2 (13%) | 9 (60%) | 1 (7%) | 2 (13%) |
| B-symptoms pos. (n = 16) | 15 (94%) | 6 (38%) | 1 (6%) | 8 (50%) | — | 1 (6%) |
| . | No. of patients (%) . | |||||
|---|---|---|---|---|---|---|
| OR . | CR . | CRu . | PR . | NC . | PD . | |
| Total group (n = 31) | 27 (87%) | 7 (23%) | 3 (10%) | 17 (55%) | 1 (3%) | 3 (9%) |
| First-line patient (n = 20) | 17 (85%) | 4 (20%) | 1 (5%) | 12 (60%) | — | 3 (15%) |
| Pretreated patient (n = 11) | 10 (90%) | 3 (27%) | 2 (18%) | 5 (45%) | 1 (9%) | — |
| Binet B (n = 21) | 20 (95%) | 6 (29%) | 3 (14%) | 11 (52%) | — | 1 (5%) |
| Binet C (n = 10) | 7 (70%) | 1 (10%) | — | 6 (60%) | 1 (10%) | 2 (20%) |
| No B-symptoms (n = 15) | 12 (80%) | 1 (7%) | 2 (13%) | 9 (60%) | 1 (7%) | 2 (13%) |
| B-symptoms pos. (n = 16) | 15 (94%) | 6 (38%) | 1 (6%) | 8 (50%) | — | 1 (6%) |
NC indicates no change.